IperionX Shares Jump as New Press Triples Titanium Production Capacity

IperionX shares (ASX:IPX) have jumped 5% today as news that the firm commissioned a cutting-edge six-axis powder metallurgy press at its Virginia facility, tripling manufacturing capacity for high-value titanium components marked a significant milestone in the company’s transition to industrial-scale domestic production.

The IperionX share price has climbed 5.15% to A$4.90 as markets work through the implications of the capacity expansion. The move comes after a volatile 12 months that has seen holders have to deal with both enthusiasm around its domestic titanium supply chain and scrutiny from short-sellers questioning the commercial viability of its technology platform. Shares are down 15.5% so far this year, although firmly higher if you zoom out, with a 37% 1 year gain, and a 389% jump over the past 5 years.

Capacity Expansion

IperionX announced it has successfully commissioned a 300-ton, six-axis SACMI powder metallurgy press at its Titanium Manufacturing Campus in Virginia, a facility that has been the focal point of the company’s strategy to establish an integrated scrap-to-component titanium supply chain on U.S. soil. The newly installed press represents a substantial leap in both capacity and capability, designed to support production rates of up to 11 million parts annually when operating with single-cavity tooling, a figure that management describes as aspirational capacity rather than immediate output.

The SACMI equipment enables IperionX to manufacture more complex titanium components with tighter tolerances and improved repeatability compared to its earlier 100-ton uniaxial press. This enhanced capability opens the door to higher-value defence and aerospace applications, including fasteners, gears, brackets, and other near-net-shape parts that require multi-level geometries and strict dimensional specifications. The press is engineered to integrate with new HSPT sintering and forging furnaces scheduled to arrive at the campus in June, creating a complete powder-metallurgy production line that management believes will reduce costs, waste, and lead times relative to traditional titanium manufacturing methods.

The capacity expansion comes as IperionX transitions its Virginia operations to a 24-hour, seven-day production schedule, a shift detailed in the company’s March 2026 quarterly report released in late April. During that quarter, the facility’s HAMR titanium powder production systems reached output of approximately 4.2 tonnes in March, establishing an early baseline equivalent to roughly 50 tonnes per annum on an annualised basis. Management has set a target of approximately 200 tonnes per annum of titanium powder by the end of calendar year 2026, implying a four-fold ramp over the next 18 to 20 months as additional equipment is optimised and customer programs scale.

The company’s manufacturing platform relies on titanium powder produced in-house from U.S.-sourced feedstocks, including scrap material, processed through IperionX’s patented HAMR technology. This approach is designed to bypass traditional Kroll-based supply chains and reduce dependence on titanium imports from China and Russia, a strategic positioning that has attracted support from the U.S. Department of Defense. In 2025, the DoD obligated US$12.5 million under a larger US$47.1 million award through the Industrial Base Analysis and Sustainment programme, with funds earmarked to accelerate expansion of titanium metal and manufacturing capacity at the Virginia site.

Recent Developments

The SACMI press commissioning represents the latest step in a multi-year build-out of the Virginia campus. In January 2026, IperionX announced it had completed commissioning of equipment and systems for titanium powder production and component manufacturing, marking the transition from construction and installation phases to operational ramp-up. The March quarterly update confirmed that all major scrap-to-forged titanium production assets are online, with the company now focused on progressively expanding product development and customer programmes as capacity increases.

Beyond the newly commissioned SACMI press, the facility houses a 100-ton uniaxial press that is being optimised for 24-hour defence fastener production, as well as a cold isostatic press for larger components. The addition of multiple HSPT sintering furnaces through the June quarter and into the second half of 2026 is intended to relieve bottlenecks in the powder-to-part production flow, enabling higher throughput and faster customer qualification cycles.

Management has guided that customer receipts should build and revenues scale in the second half of calendar year 2026, contingent on qualification milestones and purchase-order timing. This timeline places IperionX in a critical period where operational momentum must translate into contracted volumes and recurring cashflow to validate the capital invested in the campus infrastructure.

Industry Backdrop

IperionX’s capacity expansion unfolds against a backdrop of heightened attention to titanium supply chain security in the United States. Defence and aerospace manufacturers have grown increasingly concerned about reliance on Chinese and Russian titanium, particularly as geopolitical tensions have underscored the vulnerability of offshore supply chains. The company’s ability to produce titanium components domestically from scrap feedstock aligns with policy priorities around reshoring critical materials and reducing carbon intensity, given that its HAMR process is marketed as lower-emission compared to traditional Kroll reduction.

However, the path to commercial scale is not without sceptics. In November 2025, short-seller Spruce Point Capital released a report questioning the commercial viability and scalability of IperionX’s technology versus entrenched incumbents. The company issued a detailed rebuttal, and continued Department of Defense funding after the report provided some validation of key counterparties’ confidence. Nonetheless, the critique highlighted execution and financing risks that remain part of the investment debate, particularly around capital intensity, timelines to meaningful cashflow, and the need for further equity raises if revenue build is slower than anticipated.

What Next?

The tripling of press-side capacity while HAMR powder production ramps creates operating leverage if customer awards materialise, allowing IperionX to spread largely fixed campus overheads across higher throughput. The ability to produce more complex geometries opens higher-value programmes, particularly in defence and aerospace where material yield, lead times, and domestic sourcing can justify premium pricing. The strategic narrative around reshoring U.S. titanium supply chains plays well with government support and defence demand tailwinds, reinforcing the bull case that IperionX is building a platform with structural advantages in a supply-constrained market.

Yet the expansion also raises familiar questions around capital deployment and return on invested capital. A significant increase in installed capacity ahead of matching revenue scale means that utilisation rates and qualification cycle timing become critical variables. The 11-million-parts-per-year figure is aspirational capacity; no matching volume contracts were announced alongside the SACMI commissioning. Bulls must assume that future orders will arrive to fill the expanded production lines, while bears will stress that the story remains capex- and narrative-heavy relative to current cashflow.

Simultaneously ramping powder production, multiple pressing technologies, and sintering furnaces is operationally complex, introducing execution risk that is non-trivial for a company still in the early stages of commercial-scale operations. Customer qualification in defence and aerospace can be lengthy and unforgiving, and any delays in purchase-order timing or scope changes in government programmes could affect both capital flows and revenue inflection points.

For now at least, IperionX shares remain a high-conviction bet on the reshoring of U.S titanium supply chains, with execution risk and financing needs balanced against the strategic value of a rare domestic production platform in a geopolitically sensitive material.